Renown Institute for Cancer Welcomes New Physicians|
RENO, Nev. (Dec. 12, 2008) – Renown Institute for Cancer is pleased to announce the addition of four new physicians. The institute offers specialized cancer treatment programs where oncologists, radiologists, nurses and other health professionals bring the best of their specialties to each patient's needs.
Combining advanced technology with the best professionals from all over the country, patients receive sophisticated treatment along with patient-focused care. This special blend research and experienced-care gives patients every advantage over this disease. The new physicians include the following:
Medical Oncologist – Aaron Bowman, M.D., with Reno Oncology Consultants, earned his medical degree at Ohio State University and served his residency at the University of Utah in internal medicine. He remained there for an oncology specialty fellowship.
In the world of oncology, Dr. Bowman said there is much to be hopeful about as medical researchers are finding more ways to target specific markers in the cancer cells themselves. Patients can be assured doctors at Renown Health offer leading-edge treatments and state-of-the-art technology in cancer care.
Gastrointestinal Surgical Oncologist – Christos Galanopoulos, M.D. with General & Vascular Associates, earned his medical degree at Rush Medical College in Chicago, Ill. and then served residencies at Rush-Presbyterian St. Luke’s Medical Center, Cook County Hospital and the University of Illinois Medical Center. He earned a Hepato-Pancreato-Biliary/Foregut fellowship at Methodist Dallas Medical Center, which is one of only six medical programs in the United States that offers an accredited fellowship in the specialty.
According to Dr. Galanopoulos, cancers of the gastrointestinal track are some of the most complicated. Until recently, the northern Nevada region had no specialists in the field.
Hematologist/Oncologist– Sowjanya Reganti, M.D. with Alpine Hematology & Oncology, earned her medical degree at Bangalore University in India and then completed her residency at Advocate Lutheran General Hospital in Chicago, Ill. After her residency, she went on to finish her fellowship in hematology/oncology at Loyola University Medical Center, Chicago.
Medical Director of Radiation/Oncology – After earning his medical degree at Northeastern Ohio University College of Medicine, Eric Rost, M.D., with Renown Health, went on to train in internal medicine at George Washington University in Washington D.C. He later trained in nuclear medicine and radiology at Johns Hopkins University in Baltimore, Md. Dr. Rost also trained in radiation sciences at Columbia-Presbyterian Medical Center in New York and the University of Miami.
Dr. Rost went on to develop a variety of prestigious cancer centers. Most recently, he served with Cancer Hope, a not-for-profit foundation dedicated to individualized cancer care. He’s highly regarded in the medical world and frequently lectures on modern radiation techniques.
Colon and Rectal Surgical Oncologist – Mary Schultheis, M.D. with General & Vascular Associates, earned her medical degree at Creighton University in Omaha, Neb. and served her residency at St. Agnes Hospital in Baltimore, Md. in general surgery. She later completed her fellowship at Greater Baltimore Medical Center in Colon and Rectal surgery.
Dr. Schultheis is certified in laparoscopic surgery, a minimally invasive approach, which provides the optimum treatment for rectal cancer. More importantly, she is also Board Certified in general surgery and Board Eligible in colorectal and rectal surgery. Joining Renown has allowed her to practice in a setting where technology has changed the way we think about cancer treatment, she said.
About Renown Institute for Cancer Renown Institute for Cancer was the region’s first hospital recognized by the American College of Surgeons Commission on Cancer for comprehensive cancer care for more than 22 years. Only 25 percent of hospitals nationwide meet the Commission’s rigorous standards.
In October 2008, Renown Institute for Cancer announced a new piece of equipment called TomoTherapy, which will expand doctors’ ability to use therapeutic radiation to treat tumors with 3-D imaging and improved precision. When installed in December, the new Hi-Art® system will have applications for an assortment of cancer treatments across many disciplines treating cancers throughout the entire body. More specifically, mesothelioma, an asbestos-related cancer of the lining of the lung or the lining of the abdominal cavity, can only be treated with TomoTherapy.
Renown Institute for Cancer is the largest healthcare provider in the area conducting clinical trials with the National Cancer Institute. Clinical trials allow patients to be on leading trends in medicine and often times they become involved in that "next big discovery" for cancer treatments. Leading northern Nevada in cancer research, Renown Institute for Cancer has administered more than 135 trials to 870 participants.
Whether individuals have been referred, are currently receiving treatment or are seeking a second opinion, they can make an appointment at Renown Institute for Cancer anytime. The team of skilled professionals bring expertise and comprehensive resources to patient care. For general inquiries, contact 775-982-6830 or visit www.renown.org.